Which Drug Prices Should Medicare Negotiate? A "Too Little" or "Too Late" Approach. Academic Article uri icon

Overview

publication date

  • November 28, 2019

Research

keywords

  • Cost Control
  • Drug Costs
  • Drug Industry
  • Medicare
  • Negotiating

Identity

Scopus Document Identifier

  • 85075729586

Digital Object Identifier (DOI)

  • 10.1056/NEJMp1912736

PubMed ID

  • 31774952

Additional Document Info

volume

  • 381

issue

  • 22